About Hemangio
Our mission is to build the space we needed when we were in the same position you are now.
We aim to be the bridge between you and the most valuable resources to assist you on your journey, building a supportive community to walk alongside you and empowering veterinary professionals to continue providing their best care for canine patients.
Where it all began
Our Impact
5MM
Committed
15
World’s Top Medical Experts as Advisors
100+
Dogs & their Families Supported
We’re proud to be a 501(c)3 nonprofit organization.
We are proud to be a 501(c)3 nonprofit organization, dedicated to making a difference in the lives of dogs and their families facing hemangiosarcoma. We are committed to driving awareness, providing educational resources, and supporting vital research initiatives. Through a community-oriented approach, we strive to improve the quality of life for dogs diagnosed with this aggressive form of cancer. Your support is invaluable in helping us achieve these goals.
Recent Updates
LDH and Cholesterol Metabolism in Canine HSA
Lactate and cholesterol metabolism are linked in HSA, and a statin-dipyridamole combo slowed tumour growth in mice.
Published on: August 16, 2026
RNA Expression Reveals Distinct Subtypes of Canine Splenic HSA
A new study using gene expression profiling has identified three molecular subtypes of canine splenic hemangiosarcoma, each with different therapeutic implications.
Published on: August 8, 2026
Lipid Radiosensitizer Suppresses HSA Growth Without Direct Cell Kill
The lipid compound shrank hemangiosarcoma tumors in mice by remodeling the environment around the tumor.
Published on: July 17, 2026
Doxorubicin as Rescue Therapy for Acute Hemorrhage in Presumed HSA
Doxorubicin extended median survival to 82 days in dogs with acute hemorrhage from presumed hemangiosarcoma where surgery was not an option.
Published on: July 10, 2026
Liquid Biopsy Screening Could Double Cancer Detection in Dogs
Adding blood-based liquid biopsy to wellness visits increased preclinical cancer detection from 12% to 55% in a 419-dog screening study.
Published on: July 6, 2026
UV Light as a Risk Factor for Dermal HSA
A 2026 review explores the link between UV exposure and dermal hemangiosarcoma in dogs
Published on: June 28, 2026